PDS Biotechnology Corp Financing Cash Flow
PDS Biotechnology Corp (PDSB) reported Financing Cash Flow of -$13.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- PDS Biotechnology Corp net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$13.27M, a 1432.58% decline year-over-year.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$679.83K, a 109.29% decline year-over-year.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $4.22M, a 2340.07% increase year-over-year.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $241.21K, a 1301.05% increase year-over-year.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for fiscal 2025 was $12.77M, a 36.72% decline from fiscal 2024.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for fiscal 2024 was $20.19M, a 23.28% increase from fiscal 2023.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for fiscal 2023 was $16.38M, a 52.24% decline from fiscal 2022.
- PDS Biotechnology Corp net cash provided by (used in) financing activities for fiscal 2022 was $34.29M, a 29.87% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$13.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$13.95M 10-Q · filed 2026-08-13 | -$9.74M derived: sum of 3 quarters · filed 2026-08-13 | -$9.49M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$679.83K 10-Q · filed 2026-05-14 | $3.54M derived: sum of 2 quarters · filed 2026-05-14 | $3.78M derived: sum of 3 quarters · filed 2026-05-14 | $4.77M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $4.46M derived: sum of 2 quarters · filed 2026-03-30 | $5.45M derived: sum of 3 quarters · filed 2026-08-13 | $12.77M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $241.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.24M derived: sum of 2 quarters · filed 2026-08-13 | $8.56M 10-Q · filed 2025-11-13 | $8.73M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $995.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $8.32M 10-Q · filed 2026-08-13 | $8.49M derived: sum of 3 quarters · filed 2026-08-13 | $8.51M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $7.32M 10-Q · filed 2026-05-14 | $7.49M derived: sum of 2 quarters · filed 2026-05-14 | $7.51M derived: sum of 3 quarters · filed 2026-05-14 | $7.50M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $172.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $189.99K derived: sum of 2 quarters · filed 2026-03-30 | $176.21K derived: sum of 3 quarters · filed 2026-03-30 | $20.19M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $17.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.43K derived: sum of 2 quarters · filed 2025-11-13 | $20.02M 10-Q · filed 2025-11-13 | $30.78M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$13.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $20.00M 10-Q · filed 2025-08-13 | $30.76M derived: sum of 3 quarters · filed 2025-08-13 | $31.57M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $20.01M 10-Q · filed 2025-05-14 | $30.78M derived: sum of 2 quarters · filed 2025-05-14 | $31.58M derived: sum of 3 quarters · filed 2025-05-14 | $31.82M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $11.57M derived: sum of 2 quarters · filed 2025-03-27 | $11.81M derived: sum of 3 quarters · filed 2025-03-27 | $16.38M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $802.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.04M derived: sum of 2 quarters · filed 2024-11-14 | $5.61M 10-Q · filed 2024-11-14 | $15.32M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $240.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.81M 10-Q · filed 2024-08-13 | $14.51M derived: sum of 3 quarters · filed 2024-08-13 | $39.07M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $4.57M 10-Q · filed 2024-05-15 | $14.27M derived: sum of 2 quarters · filed 2024-05-15 | $38.83M derived: sum of 3 quarters · filed 2024-05-15 | $38.85M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $34.26M derived: sum of 2 quarters · filed 2024-03-28 | $34.28M derived: sum of 3 quarters · filed 2024-03-28 | $34.29M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $24.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $24.57M derived: sum of 2 quarters · filed 2023-11-14 | $24.58M 10-Q · filed 2023-11-14 | $24.58M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $22.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $29.92K 10-Q · filed 2023-08-14 | $29.93K derived: sum of 3 quarters · filed 2023-08-14 | $153.44K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $7.49K 10-Q · filed 2023-05-15 | $7.50K derived: sum of 2 quarters · filed 2023-05-15 | $131.01K derived: sum of 3 quarters · filed 2023-05-15 | $48.90M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $13.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $123.52K derived: sum of 2 quarters · filed 2023-03-28 | $48.89M derived: sum of 3 quarters · filed 2023-03-28 | $48.89M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | $123.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $48.89M derived: sum of 2 quarters · filed 2022-11-14 | $48.89M 10-Q · filed 2022-11-14 | $48.89M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $48.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $48.77M 10-Q · filed 2022-08-08 | $48.77M derived: sum of 3 quarters · filed 2022-08-08 | $66.55M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-05-11 | $17.79M derived: sum of 3 quarters · filed 2022-05-11 | $17.79M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $17.79M derived: sum of 2 quarters · filed 2022-03-31 | $17.79M derived: sum of 3 quarters · filed 2022-03-31 | $29.83M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $17.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $17.79M derived: sum of 2 quarters · filed 2021-11-10 | $29.83M 10-Q · filed 2021-11-10 | $29.83M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $12.04M 10-Q · filed 2021-08-12 | $12.04M derived: sum of 3 quarters · filed 2021-08-12 | $12.04M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $12.04M 10-Q · filed 2021-05-13 | $12.04M derived: sum of 2 quarters · filed 2021-05-13 | $12.04M derived: sum of 3 quarters · filed 2021-05-13 | $12.04M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | $0.00 derived: sum of 3 quarters · filed 2021-03-18 | $750.00K 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $750.00K 10-Q · filed 2020-11-13 | $1.03M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $750.00K 10-Q · filed 2020-08-13 | $1.03M derived: sum of 3 quarters · filed 2020-08-13 | $1.20M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $750.00K 10-Q · filed 2020-05-13 | $1.03M derived: sum of 2 quarters · filed 2020-05-13 | $1.20M derived: sum of 3 quarters · filed 2020-05-13 | $1.19M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $278.65K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $448.41K derived: sum of 2 quarters · filed 2020-03-27 | $444.87K derived: sum of 3 quarters · filed 2020-03-27 | $1.50M 10-K · filed 2020-03-27 | -$20.27M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | $169.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $166.21K derived: sum of 2 quarters · filed 2019-11-07 | $1.22M 10-Q · filed 2019-11-07 | -$20.27M 10-Q · filed 2018-11-01 | $1.25M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | -$3.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $1.05M 10-Q · filed 2019-08-01 | -$20.27M 10-Q · filed 2018-08-01 | $1.08M derived: sum of 3 quarters · filed 2019-08-01 | $1.12M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2018-03-31 | $1.05M 10-Q · filed 2019-05-14 | $631.20K 10-Q · filed 2018-05-01 | $1.08M derived: sum of 2 quarters · filed 2019-05-14 | $1.13M derived: sum of 3 quarters · filed 2019-05-14 | $23.55M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $28.43K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $75.61K derived: sum of 2 quarters · filed 2019-02-21 | $22.50M derived: sum of 3 quarters · filed 2019-02-21 | $22.55M 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | $47.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $22.47M derived: sum of 2 quarters · filed 2018-11-01 | $22.53M 10-Q · filed 2018-11-01 | $22.53M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $22.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $22.48M 10-Q · filed 2018-08-01 | $22.49M derived: sum of 3 quarters · filed 2018-08-01 | $33.19M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | $54.70K 10-Q · filed 2018-05-01 | $62.57K derived: sum of 2 quarters · filed 2018-05-01 | $10.76M derived: sum of 3 quarters · filed 2018-05-01 | |||||
| 2016-12-31 | $7.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $10.71M derived: sum of 2 quarters · filed 2018-03-01 | $9.08M 10-K · filed 2018-03-01 | |||||
| 2016-09-30 | $10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $9.08M 10-Q · filed 2017-11-01 | ||||||
| 2016-06-30 | -$1.62M 10-Q · filed 2017-08-01 | |||||||
| 2015-12-31 | $139.52M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |